Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
The global Renin-Inhibitors market was valued at 70.79 Million USD in 2020 and will grow with a CAGR of 6.8% from 2020 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Renin inhibitors are one of four classes of compounds that affect the renin-angiotensin-aldosterone system. Renin inhibitors produce vasodilation by inhibiting the activity of renin, which is responsible for stimulating angiotensin II formation. Renin is a proteolytic enzyme that is released by the kidneys in response to sympathetic activation, hypotension, and decreased sodium delivery to the distal renal tubule. Aliskiren (INN) (trade names Tekturna, US; Rasilez, UK and elsewhere) is the first in a class of drugs called direct renin inhibitors. Its current licensed indication is essential (primary) hypertension.USA is still the largest consumption region of Tekturna, occupied about 56% market share globally, with revenue 39.21 million USD in 2017. At the same time, Asia will see the considerable growth since Noden Pharma DAC had successfully entered into an agreement with Orphan Pacific (Japan) and Lee`s Pharmaceutical Holdings Limited (China).
By Market Verdors:
Novartis
Noden Pharma
By Types:
150mg/Tablet
300mg/Tablet
By Applications:
Age below 45
Age 45-55
Age 55-65
Age above 65
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Renin-Inhibitors Market Size Analysis from 2022 to 2027
1.5.1 Global Renin-Inhibitors Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Renin-Inhibitors Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Renin-Inhibitors Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Renin-Inhibitors Industry Impact
Chapter 2 Global Renin-Inhibitors Competition by Types, Applications, and Top Regions and Countries
2.1 Global Renin-Inhibitors (Volume and Value) by Type
2.1.1 Global Renin-Inhibitors Consumption and Market Share by Type (2016-2021)
2.1.2 Global Renin-Inhibitors Revenue and Market Share by Type (2016-2021)
2.2 Global Renin-Inhibitors (Volume and Value) by Application
2.2.1 Global Renin-Inhibitors Consumption and Market Share by Application (2016-2021)
2.2.2 Global Renin-Inhibitors Revenue and Market Share by Application (2016-2021)
2.3 Global Renin-Inhibitors (Volume and Value) by Regions
2.3.1 Global Renin-Inhibitors Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Renin-Inhibitors Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Renin-Inhibitors Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Renin-Inhibitors Consumption by Regions (2016-2021)
4.2 North America Renin-Inhibitors Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Renin-Inhibitors Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Renin-Inhibitors Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Renin-Inhibitors Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Renin-Inhibitors Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Renin-Inhibitors Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Renin-Inhibitors Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Renin-Inhibitors Sales, Consumption, Export, Import (2016-2021)
4.10 South America Renin-Inhibitors Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Renin-Inhibitors Market Analysis
5.1 North America Renin-Inhibitors Consumption and Value Analysis
5.1.1 North America Renin-Inhibitors Market Under COVID-19
5.2 North America Renin-Inhibitors Consumption Volume by Types
5.3 North America Renin-Inhibitors Consumption Structure by Application
5.4 North America Renin-Inhibitors Consumption by Top Countries
5.4.1 United States Renin-Inhibitors Consumption Volume from 2016 to 2021
5.4.2 Canada Renin-Inhibitors Consumption Volume from 2016 to 2021
5.4.3 Mexico Renin-Inhibitors Consumption Volume from 2016 to 2021
Chapter 6 East Asia Renin-Inhibitors Market Analysis
6.1 East Asia Renin-Inhibitors Consumption and Value Analysis
6.1.1 East Asia Renin-Inhibitors Market Under COVID-19
6.2 East Asia Renin-Inhibitors Consumption Volume by Types
6.3 East Asia Renin-Inhibitors Consumption Structure by Application
6.4 East Asia Renin-Inhibitors Consumption by Top Countries
6.4.1 China Renin-Inhibitors Consumption Volume from 2016 to 2021
6.4.2 Japan Renin-Inhibitors Consumption Volume from 2016 to 2021
6.4.3 South Korea Renin-Inhibitors Consumption Volume from 2016 to 2021
Chapter 7 Europe Renin-Inhibitors Market Analysis
7.1 Europe Renin-Inhibitors Consumption and Value Analysis
7.1.1 Europe Renin-Inhibitors Market Under COVID-19
7.2 Europe Renin-Inhibitors Consumption Volume by Types
7.3 Europe Renin-Inhibitors Consumption Structure by Application
7.4 Europe Renin-Inhibitors Consumption by Top Countries
7.4.1 Germany Renin-Inhibitors Consumption Volume from 2016 to 2021
7.4.2 UK Renin-Inhibitors Consumption Volume from 2016 to 2021
7.4.3 France Renin-Inhibitors Consumption Volume from 2016 to 2021
7.4.4 Italy Renin-Inhibitors Consumption Volume from 2016 to 2021
7.4.5 Russia Renin-Inhibitors Consumption Volume from 2016 to 2021
7.4.6 Spain Renin-Inhibitors Consumption Volume from 2016 to 2021
7.4.7 Netherlands Renin-Inhibitors Consumption Volume from 2016 to 2021
7.4.8 Switzerland Renin-Inhibitors Consumption Volume from 2016 to 2021
7.4.9 Poland Renin-Inhibitors Consumption Volume from 2016 to 2021
Chapter 8 South Asia Renin-Inhibitors Market Analysis
8.1 South Asia Renin-Inhibitors Consumption and Value Analysis
8.1.1 South Asia Renin-Inhibitors Market Under COVID-19
8.2 South Asia Renin-Inhibitors Consumption Volume by Types
8.3 South Asia Renin-Inhibitors Consumption Structure by Application
8.4 South Asia Renin-Inhibitors Consumption by Top Countries
8.4.1 India Renin-Inhibitors Consumption Volume from 2016 to 2021
8.4.2 Pakistan Renin-Inhibitors Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Renin-Inhibitors Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Renin-Inhibitors Market Analysis
9.1 Southeast Asia Renin-Inhibitors Consumption and Value Analysis
9.1.1 Southeast Asia Renin-Inhibitors Market Under COVID-19
9.2 Southeast Asia Renin-Inhibitors Consumption Volume by Types
9.3 Southeast Asia Renin-Inhibitors Consumption Structure by Application
9.4 Southeast Asia Renin-Inhibitors Consumption by Top Countries
9.4.1 Indonesia Renin-Inhibitors Consumption Volume from 2016 to 2021
9.4.2 Thailand Renin-Inhibitors Consumption Volume from 2016 to 2021
9.4.3 Singapore Renin-Inhibitors Consumption Volume from 2016 to 2021
9.4.4 Malaysia Renin-Inhibitors Consumption Volume from 2016 to 2021
9.4.5 Philippines Renin-Inhibitors Consumption Volume from 2016 to 2021
9.4.6 Vietnam Renin-Inhibitors Consumption Volume from 2016 to 2021
9.4.7 Myanmar Renin-Inhibitors Consumption Volume from 2016 to 2021
Chapter 10 Middle East Renin-Inhibitors Market Analysis
10.1 Middle East Renin-Inhibitors Consumption and Value Analysis
10.1.1 Middle East Renin-Inhibitors Market Under COVID-19
10.2 Middle East Renin-Inhibitors Consumption Volume by Types
10.3 Middle East Renin-Inhibitors Consumption Structure by Application
10.4 Middle East Renin-Inhibitors Consumption by Top Countries
10.4.1 Turkey Renin-Inhibitors Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Renin-Inhibitors Consumption Volume from 2016 to 2021
10.4.3 Iran Renin-Inhibitors Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Renin-Inhibitors Consumption Volume from 2016 to 2021
10.4.5 Israel Renin-Inhibitors Consumption Volume from 2016 to 2021
10.4.6 Iraq Renin-Inhibitors Consumption Volume from 2016 to 2021
10.4.7 Qatar Renin-Inhibitors Consumption Volume from 2016 to 2021
10.4.8 Kuwait Renin-Inhibitors Consumption Volume from 2016 to 2021
10.4.9 Oman Renin-Inhibitors Consumption Volume from 2016 to 2021
Chapter 11 Africa Renin-Inhibitors Market Analysis
11.1 Africa Renin-Inhibitors Consumption and Value Analysis
11.1.1 Africa Renin-Inhibitors Market Under COVID-19
11.2 Africa Renin-Inhibitors Consumption Volume by Types
11.3 Africa Renin-Inhibitors Consumption Structure by Application
11.4 Africa Renin-Inhibitors Consumption by Top Countries
11.4.1 Nigeria Renin-Inhibitors Consumption Volume from 2016 to 2021
11.4.2 South Africa Renin-Inhibitors Consumption Volume from 2016 to 2021
11.4.3 Egypt Renin-Inhibitors Consumption Volume from 2016 to 2021
11.4.4 Algeria Renin-Inhibitors Consumption Volume from 2016 to 2021
11.4.5 Morocco Renin-Inhibitors Consumption Volume from 2016 to 2021
Chapter 12 Oceania Renin-Inhibitors Market Analysis
12.1 Oceania Renin-Inhibitors Consumption and Value Analysis
12.2 Oceania Renin-Inhibitors Consumption Volume by Types
12.3 Oceania Renin-Inhibitors Consumption Structure by Application
12.4 Oceania Renin-Inhibitors Consumption by Top Countries
12.4.1 Australia Renin-Inhibitors Consumption Volume from 2016 to 2021
12.4.2 New Zealand Renin-Inhibitors Consumption Volume from 2016 to 2021
Chapter 13 South America Renin-Inhibitors Market Analysis
13.1 South America Renin-Inhibitors Consumption and Value Analysis
13.1.1 South America Renin-Inhibitors Market Under COVID-19
13.2 South America Renin-Inhibitors Consumption Volume by Types
13.3 South America Renin-Inhibitors Consumption Structure by Application
13.4 South America Renin-Inhibitors Consumption Volume by Major Countries
13.4.1 Brazil Renin-Inhibitors Consumption Volume from 2016 to 2021
13.4.2 Argentina Renin-Inhibitors Consumption Volume from 2016 to 2021
13.4.3 Columbia Renin-Inhibitors Consumption Volume from 2016 to 2021
13.4.4 Chile Renin-Inhibitors Consumption Volume from 2016 to 2021
13.4.5 Venezuela Renin-Inhibitors Consumption Volume from 2016 to 2021
13.4.6 Peru Renin-Inhibitors Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Renin-Inhibitors Consumption Volume from 2016 to 2021
13.4.8 Ecuador Renin-Inhibitors Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Renin-Inhibitors Business
14.1 Novartis
14.1.1 Novartis Company Profile
14.1.2 Novartis Renin-Inhibitors Product Specification
14.1.3 Novartis Renin-Inhibitors Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Noden Pharma
14.2.1 Noden Pharma Company Profile
14.2.2 Noden Pharma Renin-Inhibitors Product Specification
14.2.3 Noden Pharma Renin-Inhibitors Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Renin-Inhibitors Market Forecast (2022-2027)
15.1 Global Renin-Inhibitors Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Renin-Inhibitors Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Renin-Inhibitors Value and Growth Rate Forecast (2022-2027)
15.2 Global Renin-Inhibitors Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Renin-Inhibitors Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Renin-Inhibitors Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Renin-Inhibitors Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Renin-Inhibitors Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Renin-Inhibitors Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Renin-Inhibitors Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Renin-Inhibitors Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Renin-Inhibitors Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Renin-Inhibitors Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Renin-Inhibitors Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Renin-Inhibitors Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Renin-Inhibitors Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Renin-Inhibitors Consumption Forecast by Type (2022-2027)
15.3.2 Global Renin-Inhibitors Revenue Forecast by Type (2022-2027)
15.3.3 Global Renin-Inhibitors Price Forecast by Type (2022-2027)
15.4 Global Renin-Inhibitors Consumption Volume Forecast by Application (2022-2027)
15.5 Renin-Inhibitors Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
Request Sample 
Request Discount 
Inquire Before Buy
